Comments
Commented by Nico Popp on September 17th, 2025 | 07:00 CEST
Tokenization as an efficiency booster: Finexity, London Stock Exchange, eToro
Digitalization has fundamentally changed the way we invest. What began decades ago with the rise of online brokers is now continuing with tokenized assets and the use of AI. As the CFA Institute writes, the use of blockchain technology means faster transactions, less settlement friction, and ultimately lower costs. Innovative companies around the world are setting out to offer these advantages to better serve their customers, which is also good news for investors. We take a closer look at the business models of Finexity, the London Stock Exchange, and eToro in the field of tokenization.
Read
Commented by Stefan Feulner on September 16th, 2025 | 07:25 CEST
Broadcom, NetraMark, Adobe – The AI wave continues to roll inexorably forward
Artificial intelligence is more than just hype; it is becoming the central driver of innovation in our time. Whether in industry, medicine, mobility, or finance, this technology is changing processes, increasing efficiency and creating new business models in almost all sectors. Companies that embrace AI early on secure clear competitive advantages. At the same time, a future market with enormous potential is opening up for investors. However, despite the rosy outlook, stock picking is also required here, as many companies are significantly overvalued.
Read
Commented by Armin Schulz on September 16th, 2025 | 07:20 CEST
Building wealth with network effects and AI: How Palantir, MiMedia, and Alibaba are making investors rich
The global economy is being driven by a new type of company: scalable platform ecosystems with predictable, recurring revenues. They leverage network effects for exponential growth and are resilient to economic fluctuations. These disruptive business models, at the intersection of AI, data, and digital connectivity, generate steady cash flows and define the investment opportunities of tomorrow. Three companies that perfectly embody this strategy are Palantir, MiMedia Holdings and Alibaba.
Read
Commented by Nico Popp on September 16th, 2025 | 07:15 CEST
Defense industry expands – New growth drivers: Hensoldt, Almonty and Rheinmetall
An industry once largely overlooked by the public is now dominating the headlines. On Monday, it was announced that Rheinmetall will acquire the Marine Division of the Bremen-based Lürssen Group. This includes the Blohm + Voss shipyards, the Norderwerft shipyard in Hamburg, the Peene shipyard, and the Neue Jadewerft shipyard in Wilhelmshaven. This move underscores how the defense industry is venturing into new domains. Meanwhile, tensions between Russia and NATO continue to escalate. The drones that flew over Poland last week are considered by experts to be a serious provocation. In this context, we take a closer look at three high-flyers in the defense industry and highlight where investors may find the greatest opportunities.
Read
Commented by Fabian Lorenz on September 16th, 2025 | 07:10 CEST
OPPORTUNITY for 100% returns and a short squeeze! D-Wave Quantum, Zalando and Rio Tinto partner Aspermont
While traditional AI stocks like Nvidia, Palantir and Oracle are becoming increasingly overheated, investors are now turning their attention to second- and third-tier companies. These are companies that are poised to benefit from the adoption of AI technologies. One example is the hot stock Aspermont. The Australian company holds a massive trove of data on the global resources industry. The latest bombshell: a partnership with mining giant Rio Tinto, which is paying for access to and processing of Aspermont's valuable data. The stock has not yet reacted. At Zalando, analysts see upside potential of up to 100%. The e-commerce group could also benefit from AI advancements. And then, of course, there is quantum computing, seen as a potential challenger to AI. Could investor favorite D-Wave be on the verge of a short squeeze?
Read
Commented by André Will-Laudien on September 16th, 2025 | 07:05 CEST
Stock market with explosive potential – Where are the winners? Daimler Truck, dynaCERT and Plug Power
The stock market is currently developing very selectively. In addition to the megatrends of artificial intelligence, high-tech, and defense, investor interest is gradually shifting to future-focused sectors that have not yet felt much of the general bull market. The hydrogen sector in particular has hardly benefited from the general bullish mood so far. In addition to industrial applications within the energy transition, hydrogen technologies offer significant potential in heavy-duty transport, local transport and mining. The goal is to significantly reduce diesel consumption and thus contribute to emissions reduction. This is particularly true in cases where battery-powered trucks reach their limits in terms of range, weight, or charging times. The market for fuel cell infrastructure is growing rapidly. The EU plans to invest around EUR 5 billion in this area by 2030. Pilot projects and government subsidies are driving development forward, and private investors are now starting to take notice. Where do the opportunities for investors lie?
Read
Commented by Fabian Lorenz on September 16th, 2025 | 07:00 CEST
Hot Stock shakes up Big Pharma! BioNxt Solutions aims to replace Ozempic weight loss injection!
BioNxt is currently shaking up Big Pharma. The announcement that it plans to replace the Ozempic weight loss injection with an oral dissolvable film is once again fueling speculation about the share price. Just like in the multiple sclerosis space, the Company aims to disrupt a billion-dollar obesity market. Further exciting operational news is expected in the coming months. Key patents are already in place. With a market capitalization of around CAD 100 million, the Canadian-German life sciences company is far from expensive – even for Big Pharma. The major corporations will undoubtedly be watching BioNxt's development very closely in the coming months. Until then, the stock is likely to trade significantly higher.
Read
Commented by Armin Schulz on September 15th, 2025 | 07:25 CEST
Beyond FAANG, German tech companies such as SAP, Finexity and TeamViewer also offer potential for your portfolio
While US tech giants like Meta and Google dominate the headlines, other technology companies in Germany receive little attention. But here too, on the other side of the Atlantic, innovative companies with disruptive technologies and robust business models are shaping the future and offering unique opportunities for capital growth. Reason enough to take a closer look at three German companies: SAP, Finexity and TeamViewer. We analyze the strategic decisions and innovations that will shape the next investment success story.
Read
Commented by Fabian Lorenz on September 15th, 2025 | 07:20 CEST
Gold mining stocks in takeover fever! Barrick Mining and Newmont are selling! B2Gold neighbor Desert Gold in the crosshairs?
Takeover fever is sweeping through the gold sector. The typical cycle of the industry appears to be repeating itself once again: with the rising price of gold, which remains solidly above USD 3,600, the appetite for takeovers is also growing. Gold producers are earning more, and banks and private equity firms are opening their coffers for mergers and acquisitions. For large and small mining companies alike, the current market phase offers an opportunity to expand their portfolios, optimize projects, or reposition themselves through strategic sales and purchases. Barrick and Newmont are currently raising billions through asset sales, boosting their war chests. In contrast, Desert Gold - a neighbor of B2Gold - could soon see a partner come on board or even become an acquisition target. Analysts see significant upside potential for the share.
Read
Commented by Nico Popp on September 15th, 2025 | 07:15 CEST
No more diet injections! Innovations in weight loss drugs: BioNxt Solutions, Merck & Co., Novo Nordisk
As recently reported by the United Nations Children's Fund (UNICEF), for the first time, more children worldwide are obese than underweight. While this is a great success in the fight against hunger, it also poses new risks. Severe overweight in childhood leads to obesity and associated diseases in adulthood, such as cardiovascular problems and diabetes. The treatment of overweight and diabetes in children is therefore likely to play an even more significant role in the future. GLP-1 receptor agonists have been popular for several years now in the form of modern weight loss injections. With patents expiring soon, experts anticipate substantial further growth and development in this rapidly expanding market. We explain who could benefit and what the future holds for modern diet medications.
Read